Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIg for treatment-resistant painful diabetic polyneuropathy
2010-023883-42Phase 3Terminated
- Sponsor
- ASST Grande Ospedale Metropolitano Niguarda
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetic polyneuropathy (DPN) comparing High-dose IVIg with Placebo (2 arms). Primary endpoint: Change in pain intensity on visual analogue scale. Started Mar 2012; status: terminated.
02
Drugs
subcuvia
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2010-023883-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023883-42.